Technical Data
B2553-06D
Bone Morphogenetic Protein 2, Recombinant, Human (BMP2)
2ug
10ug
100ug
10ug
100ug
|
Technical Data |
|
B2553-06D |
Bone Morphogenetic Protein 2, Recombinant, Human (BMP2) |
2ug 10ug 100ug |
| Growth Factors, Cytokines | Storage: -70°CShipping: Blue Ice |
|
BMP-2 belongs to the Bone-growth regulatory factors that are members of the transforming growth factor-beta (TGF-beta) superfamily of proteins. They are synthesized as large precursor molecules which are cleaved by proteolytic enzymes. The active form can consist of a dimer of two identical proteins or a heterodimer of two related bone morphogenetic proteins. Recombinant Human Bone Morphogenetic protein-2 produced in E. coli is a homodimeric, non-glycosylated, polypeptide chain containing 115 amino acids and having a molecular mass of 26018D. Endotoxin: 0.01ng/ug or 0.1EU/ug as per LAL. Biological Activity: BMP-2 is fully biologically active when compared to standard. The ED50 as determined by the cytolysis of MC3T3-E1 cells is less then 50ng/ml. AA Sequence: MQAKHKQRKR LKSSCKRHPL YVDFSDVGWN DWIVAPPGYH AFYCHGECPF PLADHLNSTN HAIVQTLVNS VNSKIPKACC VPTELSAISM LYLDENEKVV LKNYQDMVVE GCGCR Storage and Stability: Lyophilized powder may be stored at -20°C. Stable for 12 months at -20°C. Reconstitute with sterile ddH2O, aliquot and store at -20°C. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap. Further dilutions can be made in assay buffer. Molecular Weight: 2.6kD |
Source: Recombinant, human, E. coli Purity: ~95% Analysis by RP-HPLC, Reducing and non-reducing SDS-PAGE. Form: Supplied as a lyophilized powder. Reconstitute with sterile dH2O PBS to 0.1-1mg/ml, which can be further diluted into other aqueous solutions. Important Note: This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications without the expressed written authorization of United States Biological. |
|
|
||